Physician profile
Lalin Nuth
NPI 1992933105
$411.44
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.90 · 2020: $23.06 · 2022: $19.61 · 2023: $256 · 2024: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.87 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.00 | 2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $91.07 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Exact Sciences Corporation | $48.47 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $45.15 | 2023-2024 | Arexvy, Shingrix |
| Pfizer INC. | $30.91 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.01 | 2024 | |
| Amarin Pharma, INC. | $23.06 | 2020 | |
| Idorsia Pharmaceuticals US INC | $16.43 | 2023 | Quviviq |
| Amgen INC. | $14.34 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lalin Nuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.